USTR says they have commenced a Section 301 probe of Germany regarding pharmaceuticals, to determine whether persistent underpayment for innovative pharmaceutical products by Germany is unreasonable or discriminatory

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

Russia's Foreign Minister Lavrov says nukes in Belarus balance NATO and Ukraine threats, adds NATO-Russia direct clash risks nuclear exchange, according to IRNA

Reform UK is gloomy about prospects in Makerfield, with one party source stating the Labour is ahead by 2,500 votes, according to The Guardian

USTR says they have commenced a Section 301 probe of Germany regarding pharmaceuticals, to determine whether persistent underpayment for innovative pharmaceutical products by Germany is unreasonable or discriminatory

China says Australian beef imports hit 100% of quota on June 18th

BoJ's Himino says they expect to continue increasing rates in accordance with developments in the economic, price and financial situations

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • USTR will hold a hearing in connection with these investigations on September 22nd, 2026.

Potential means/tools that could follow:

  • supplemental discounts in exchange for confidentiality of negotiated prices; and
  • mandatory variable rate rebates.

USTR Greer:

  • "I am particularly concerned with news that Germany is fast-tracking legislation that would further reduce its spending on innovative pharmaceuticals"

Related headlines

The whole workspace, free to try.

Try it free